 |
Market Research Report
Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography |
||||||
| Published by | The Insight Partners | Product code | 966299 | ||||
| Published | Content info | 179 Pages Delivery time: 1-2 business days |
|||||
| Price |
|
||||||
| Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology, Type, Indication, End User and Geography | ||
| Published: September 16, 2020 | Content info: 179 Pages |
|
Title:
Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines and Viral Vector Cancer Vaccines), Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer and Other Indications), End User (Pediatrics and Adults) and Geography.
The global cancer vaccines market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; it is estimated to grow at a CAGR of 17.2% from 2020 to 2027.
The growth of the cancer vaccines market is mainly attributed to the globally increasing incidence of cancer and rising number of initiatives related to cancer vaccines by global health research organizations and key companies. However, the commercial availability of a less number of cancer vaccines and higher costs of the same hinder the growth of the market.
Cancer vaccines either assist in the treatment of existing cancers or prevent the development of cancer. Vaccines that enhance body's natural defense capability to fight the existing cancer are as therapeutic cancer vaccines, also known as cancer treatment vaccines. Several vaccines are "autologous"; they are prepared from samples taken from the patients and are specific to that patient. Frequent government initiatives and launches drive the market for cancer vaccines. In December 2019, Cancer Research UK and Vaccitech Oncology Limited announced a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine are intended to induce an attack on cancer cells. The vaccine is likely to deliver cancer-associated antigens (MAGE A3 and NY-ESO-1) to antigen-presenting cells, i.e., dendritic cells, leading to the generation of cytotoxic T-cells by the immune system to attack and destroy the cancer cells expressing the said antigens. Thus, the constant developments in cancer vaccines are expected to accelerate the market growth during the forecast period.
Based on type, the cancer vaccines market is segmented into preventive cancer vaccines and therapeutic cancer vaccines. The preventive cancer vaccines segment held a larger share of the market in 2019, and the same segment is anticipated to register the highest CAGR during the forecast period. Increasing number of cancer patients, growth in geriatric population, rising patient understanding of cancer therapies, development in the use of cancer vaccines in combination with other treatments, and government support to trigger the production are the key factors driving the growth of the market for preventive cancer vaccines. Based on technology, the market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. Based on indication, the market is segmented into cervical cancer, prostate cancer, and other indications. On the basis of end user, the market is segmented into pediatrics and adults.
The World Health Organization (WHO), American Cancer Society, Globocan, Cancer Research UK, Centers for Disease Control and Prevention (CDC), and Clinical and Translational Immunology and Translational Research Institute, along with company websites, are a few of the major primary and secondary sources cited while preparing this report.
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global cancer vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Cancer Vaccines Global Market Report 2020-30: COVID-19 Growth and Change
Global Cancer Vaccine Partnering Terms and Agreements 2010-2020
Asia Pacific Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; Type ; Indication ; End User, and Country
Europe Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; Type ; Indication ; End User, and Country and Country
Middle East and Africa Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; Type ; Indication ; End User, and Country
North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; Type ; Indication ; End User, and Country
South and Central America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology ; Type ; Indication ; End User, and Country
Global Cancer Vaccines Market Size study, by Type, by Technology, by Indication, by End-User and Regional Forecasts 2020-2027
Asia-Pacific Cancer Vaccines Market - Growth, Trends, and Forecasts (2020 - 2025)
Cancer Vaccines Market - Growth, Trends, and Forecast (2020 - 2025)
